These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 577875)

  • 1. [Biopharmaceutic investigations with D-norpseudoephedrine. 2nd communication: Bioavaliability of a depot preparation (author's transl)].
    Frosch F
    Arzneimittelforschung; 1977; 27(5):1076-8. PubMed ID: 577875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biopharmaceutic investigations with D-norpseudoephedrine (author's transl)].
    Frosch F
    Arzneimittelforschung; 1977; 27(3):665-8. PubMed ID: 577442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma levels and renal excretion of [3H]-codeine phosphate in humans receiving tablets or depot capsules (author's transl)].
    Sinterhauf K; Bechtel WD
    Arzneimittelforschung; 1980; 30(6):1012-5. PubMed ID: 7191260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bioavailability of Ce-Ferro forte. Comparative iron load test (author's transl)].
    Richter E; Schmitt B; Zilly W
    Med Klin; 1978 Aug; 73(34):1171-5. PubMed ID: 683118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of controlled-release metoclopramide. 2nd communication: multiple dose study.
    Beckett AH; Behrendt WA; Hadzija BW
    Arzneimittelforschung; 1987 Feb; 37(2):224-8. PubMed ID: 3580027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the bioavailability and the pharmacodynamic effect of five allopurinol preparations (author's transl)].
    Jaeger H; Russmann D; Rasper J; Blome J
    Arzneimittelforschung; 1982; 32(4):438-43. PubMed ID: 6896646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of controlled-release metoclopramide. 1st communication: single dose study.
    Beckett AH; Behrendt WA; Hadzija BW
    Arzneimittelforschung; 1987 Feb; 37(2):221-4. PubMed ID: 3580026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Absolute bioavailability of a special sustained-release acetylsalicylic acid formulation].
    Lücker PW; Swoboda M; Wetzelsberger N
    Arzneimittelforschung; 1989 Mar; 39(3):391-4. PubMed ID: 2757664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)].
    Rietbrock N; Alken RG; Ebert W
    Arzneimittelforschung; 1979; 29(11):1742-5. PubMed ID: 583489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
    Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
    J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bioavailability of different brands of phenoxymethylpenicillin (author's transl)].
    Simon C; Malerczyk V; Grothkopp J
    Med Klin; 1975 Oct; 70(41):1637-40. PubMed ID: 810652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetics of rectally administered metoclopramide.
    Vergin H; Krammer R; Nitsche V; Miczka M; Strobel K; Schimmel H
    Arzneimittelforschung; 1990 Jun; 40(6):679-83. PubMed ID: 2397004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relative bioavailability of a new spironolactone preparation (author's transl)].
    Erking W; Lücker PW; Stöcker KP; Wetzelsberger K
    Arzneimittelforschung; 1979; 29(8):1184-9. PubMed ID: 583021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability between two Tramadol once-daily oral formulations.
    Hernandez-Lopez C; Martinez-Farnos L; Karhu D; Perez-Campos T; Rovira S; Encina G
    Methods Find Exp Clin Pharmacol; 2006; 28(6):373-8. PubMed ID: 16894407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A model study of bioequivalence of dissolved nifedipine from soft gelatin capsules].
    Menke G; Kausch M; Rietbrock N
    Arzneimittelforschung; 1988 Feb; 38(2):300-4. PubMed ID: 3370080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of ambroxol sustained release preparations. Part II: Single and multiple oral dose studies in man.
    Janssen TJ; Guelen PJ; Vree TB; Botterblom MH; Valducci R
    Arzneimittelforschung; 1988 Jan; 38(1):95-7. PubMed ID: 3365282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood levels and bioavailability of ascorbic acid after administration of a sustained-release formulation to humans.
    Sacharin R; Taylor T; Chasseaud LF
    Int J Vitam Nutr Res; 1977; 47(1):68-74. PubMed ID: 844951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.